This study is an international, multi-center, study of Pompe disease patients that are currently receiving enzyme-replacement therapy (ERT). The purpose of this study is to find out if the co-administration of investigational new drugs ATB200 and…
- Investigator
- Barry J Byrne
- Ages
- 18 Years - 75 Years
- Sexes
- All